Latest Regulatory Challenges News

Donaco International shareholders have overwhelmingly approved a scheme of arrangement for On Nut Road Limited to acquire the company at a significant premium, setting the stage for a major ownership change pending court approval.

Infinity Lithium secures a three-month extension for its San José lithium project amid regulatory challenges, while reshuffling its board to pivot towards Australian precious metals.

Nagambie Resources has reported a significant assay result from its newly discovered C4 antimony-gold lode, reinforcing its structural model and advancing plans for a joint venture gold treatment plant amid a fresh capital raise.

Pure Hydrogen reports a second consecutive quarter of positive cash flow, expands its international hydrogen vehicle footprint, and secures a 15-year gas project permit in Queensland.

Sunstone Metals reports promising exploration results from its Ecuadorian gold-copper projects alongside ongoing strategic discussions with multiple parties in a buoyant M&A environment.

Berkeley Energia advances critical minerals exploration with promising lithium and rubidium findings at its Conchas Project, while escalating a $1 billion arbitration against Spain over uranium project permitting. Political shifts in Spain’s nuclear policy add a new dimension to the company’s strategic outlook.

Latitude 66 has agreed to sell its 17.5% interest in the Greater Duchess Joint Venture for an upfront A$2 million, with potential for further contingent payments, while progressing exploration in Australia and Finland amid regulatory challenges.

Bulletin Resources has significantly expanded its Lake Rebecca Gold Project to 1,100 square kilometres through a strategic acquisition, while facing regulatory challenges at its Ravensthorpe Lithium Project. The company maintains a strong financial position as it prepares for upcoming exploration activities.

The Star Entertainment Group reported steady Q4 FY25 revenue of $270 million but widened its EBITDA loss to $27 million, reflecting ongoing regulatory pressures and operational challenges. The company secured $233 million from strategic investors Bally’s Corporation and Investment Holdings, while negotiations continue over its Brisbane joint venture exit.

Prescient Therapeutics has secured FDA Fast Track designation for PTX-100 in treating relapsed Cutaneous T-Cell Lymphoma and dosed the first patient in its Phase 2a trial, supported by a recent $6.8 million capital raise.

Kingsrose Mining advances its Finnmark exploration with promising new magnetic and conductive anomalies, while BHP withdraws from Central Finland to concentrate resources. Leadership changes and a robust cash position set the stage for an active year ahead.

LCL Resources has secured a A$14 million cash deal plus royalty rights by divesting its Colombian projects to Tiger Gold Corporation, while advancing promising exploration programs in Papua New Guinea.